Intrathecal Resiniferatoxin for Medication-Refractory Pain in Advanced Cancer
Intrathecal Resiniferatoxin for Medication-Refractory Pain in Advanced Cancer
About this item
Full title
Author / Creator
Publisher
Philadelphia: Oxford University Press
Journal title
Language
English
Formats
Publication information
Publisher
Philadelphia: Oxford University Press
Subjects
More information
Scope and Contents
Contents
Abstract
INTRODUCTION
Most patients with advanced cancer experience pain that wields profound functional deterioration and diminished quality of life. Resiniferatoxin (RTX) is a small, ultrapotent agonist for the transient receptor potential vanilloid-1 (TRPV1) receptor, which is highly expressed on specific primary afferent neurons (C and A-...
Alternative Titles
Full title
Intrathecal Resiniferatoxin for Medication-Refractory Pain in Advanced Cancer
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2502875398
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2502875398
Other Identifiers
ISSN
0148-396X
E-ISSN
1524-4040
DOI
10.1093/neuros/nyaa447_523
